References
- Cercelaru L, Stepan AE, Mărgăritescu C, et al. EGFR Immunoexpression
in Laryngeal Squamous Cell Carcinoma. Curr Health Sci J . 2017;
43(4):340‐344.
- Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical
outcome in patients with head and neck squamous cell carcinoma. Int J
Exp Pathol. 2005; 86(6):347‐363.
- Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of TGF-alpha and
EGFR protein in head and neck squamous cell carcinoma and patient
survival. J Natl Cancer Inst . 1998; 90(11):824‐832.
- Pai SI, Westra WH. Molecular pathology of head and neck cancer:
implications for diagnosis, prognosis, and treatment. Annu Rev
Pathol . 2009; 4:49‐70.
- Cortesina G, Martone T. Molecular metastases markers in head and neck
squamous cell carcinoma: review of the literature. Acta
Otorhinolaryngol Ital . 2006; 26(6):317‐325.
- Redaelli de Zinis LO, Nicolai P, Tomenzoli D, et al. The distribution
of lymph node metastases in supraglottic squamous cell carcinoma:
therapeutic implications. Head Neck. 2002; 24(10):913‐920.
- Yilmaz T, Hosal AS, Gedikoğlu G, Onerci M, Gürsel B. Prognostic
significance of vascular and perineural invasion in cancer of the
larynx. Am J Otolaryngol. 1998; 19(2):83‐88.
- Magnano M, Bongioannini G, Lerda W, et al. Lymphnode metastasis in
head and neck squamous cells carcinoma: multivariate analysis of
prognostic variables. J Exp Clin Cancer Res . 1999; 18(1):79‐83.
- Čelakovský P, Kalfeřt D, Smatanová K, Chrobok V, Laco J. Detection of
Cervical Lymph Node Micrometastases in Patients with Squamous Cell
Carcinoma of the Oral Cavity, Pharynx and Larynx. Acta Medica
(Hradec Kralove) . 2015; 58(2):62‐65.
- Mayers-Breiting, E., Allvi, G., Zur definition der glottische region.
Arch. Otolaryngol.1996; 11:150-152.
- Ozdek A, Sarac S, Akyol MU, Unal OF, Sungur A. Histopathological
predictors of occult lymph node metastases in supraglottic squamous
cell carcinomas. Eur Arch Otorhinolaryngol . 2000;
257(7):389‐392.
- Zimmermann M, Zouhair A, Azria D, Ozsahin M. The epidermal growth
factor receptor (EGFR) in head and neck cancer: its role and treatment
implications. Radiat Oncol. 2006; 1:11. Published 2006 May 2.
- Şimşek H, Han Ü, Önal B, Şimişek G. The expression of EGFR, cerbB2,
p16, and p53 and their relationship with conventional parameters in
squamous cell carcinoma of the larynx. Turk J Med Sci. 2014;
44(3):411‐416.
Table (1): Show the relation between EGFR expression in cervical lymph
node metastasis and T stage & tumor grade (n = 20).